US FAMILY HEALTH PLAN

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	6	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	6	1
2010	—	4	1
2009	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MS. PATRICIA LEWIS	—	52
MONFORT LEWIS	—	8

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	23
HOUSE OF REPRESENTATIVES	22
Defense Department Field Activities	9
Defense, Dept of (DOD)	7

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	27
Veterans	Veterans	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 2410111th Congress

A bill to extend the temporary suspension of duty on 1,3-Benzenedicarboxamide, N, N'-bis-(2,2,6,6-tetramethyl-4-piperidinyl)-.

2014 · second_quarter · Firm: MS. PATRICIA LEWIS

Cited source text and reported amounts

National Defense Authorization Bill FY 2015, S. 2410, HR 4435, defense health care issues.

Client expense: — · Firm income: $20,000

Matched citations: S. 2410

US FAMILY HEALTH PLAN — Lobbying Disclosure | Poliscope